The DOI matches its Crossref record.
Induction of a Fibrin-Gel Investment: An Early Event in Line 10 Hepatocarcinoma Growth Mediated by Tumor-Secreted Products
Abstract
Within a few hours of implantation in the subcutaneous space of strain 2 guinea pigs syngeneic line 10 tumors became invested in a fibrin-gel. We hypothesized that tumors might induce and modulate this fibrin-gel by secreting molecules capable of activating the host's clotting and fibrinolytic systems. To test this possibility, line 10 tumor cells, and several non-neoplastic control cells, were cultured for 2 to 4 hr in serum-free medium and the culture supernatants were assayed for their capacity to activate host inflammatory pathways. Four distinct mediator activities were recognized in line 10 tumor cell culture supernatants: a vascular permeability factor (VPF), a procoagulant (PC), a plasminogen activator (PA), and a macrophage-migration inhibitory activity (MIF). Nonmalignant control cells secreted none of these activities with the exception of rabbit kidney cells that not unexpectedly released a PA activity, presumably urokinase. Based on conditions of culture, physical and chemical properties, inhibitor studies, and kinetics of secretion, it is likely that four distinct molecules are responsible for these activities. The complexity of the culture medium was not critical but low pH was an important variable favoring PA secretion. Secretion of all mediators was inhibited by cold and that of VPF and PA by puromycin. Cytochalasin B and EDTA caused significant increases in PA secretion. The line 10 PA, like that from other sources, was irreversibly inactivated by diisopropyl fluorophosphate and is probably a serine esterase. The capacity to secrete mediators that activate important host inflammatory pathways provides tumors with a mechanism for stroma induction and may be an important factor in determining a tumor's histologic pattern and degree of malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., & Peng, Q. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.889 · Cited by 4,716
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Self-citationTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Self-citationDvorak, H. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.088 · Cited by 1,573
Self-citationAutocrine VEGF Signaling Is Required for Vascular Homeostasis
Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., Ferrara, N., Nagy, A., Roos, K. P., & Iruela-Arispe, M. L. (2007) · Cell · doi:10.1016/j.cell.2007.06.054 · Cited by 1,046
Metadata
- Authors
- Dvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., & Giovinco, P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1979-01-01
- Volume
- 122
- Issue
- 1
- Pages
- 166-174
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1905486804
- Cited by
- 230
- References
- 0
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induction of a Fibrin-Gel Investment: An Early Event in Line 10 Hepatocarcinoma Growth Mediated by Tumor-Secreted Products. https://app.cochat.ai/papers/10.4049/jimmunol.122.1.166
- The paper
- Dvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., & Giovinco, P. (1979). Induction of a Fibrin-Gel Investment: An Early Event in Line 10 Hepatocarcinoma Growth Mediated by Tumor-Secreted Products. The Journal of Immunology. https://doi.org/10.4049/jimmunol.122.1.166
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.